Related Experiment Video

Updated: May 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

[New oral anticoagulants and chronic kidney disease]

R M Bauersachs1

  • 1Medizinische Klinik IV - Max-Ratschow-Klinik für Angiologie, Klinikum Darmstadt GmbH, Grafenstrasse 9, Darmstadt, Germany. rupert.bauersachs@klinikum-darmstadt.de

Der Internist
|November 27, 2012
PubMed

Insights

As chronic kidney disease (CKD) prevalence rises, anticoagulation for atrial fibrillation and venous thromboembolism becomes complex. Careful consideration of new oral anticoagulants (NOACs) is crucial to manage bleeding risks in CKD patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Context:

  • Rising prevalence of atrial fibrillation and venous thromboembolism due to demographic shifts.
  • Increasing challenge in anticoagulation management due to the growing incidence of chronic kidney disease (CKD).
  • CKD is linked to elevated bleeding risk and reduced oral anticoagulation (OAC) efficacy.

Purpose:

  • To analyze the impact of chronic kidney disease (CKD) on anticoagulation therapy.
  • To evaluate the risks and pharmacological properties of new oral anticoagulants (NOACs) in CKD patients.
  • To provide insights for clinical practice regarding anticoagulation in patients with impaired kidney function.

Summary:

  • New oral anticoagulants (NOACs) are renally excreted, posing accumulation risks and increasing bleeding potential in patients with chronic kidney disease (CKD).
  • Understanding the pharmacokinetics of NOACs is essential for safe and effective anticoagulation in CKD.
  • Evidence analysis highlights the need for careful drug selection and dosing in this vulnerable population.

Impact:

  • Informs clinical decision-making for anticoagulation management in patients with chronic kidney disease (CKD).
  • Aims to reduce serious complications associated with NOAC use in CKD.
  • Contributes to optimizing patient outcomes by addressing the interplay between kidney function and anticoagulant therapy.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...